Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Clover Health Investments
CLOV
$2.23B
| $109K | ﹤0.01% |
138,819
+19
| +0% | +$17 |
|
|
IRBT
2502
DELISTED
iRobot
IRBT
| $107K | ﹤0.01% |
12,284
| – | – |
|
|
VLD
2503
DELISTED
Velo3D, Inc.
VLD
| $107K | ﹤0.01% |
6,722
+18
| +0.3% | +$203 |
|
2504
iHeartMedia
IHRT
$531M
| $105K | ﹤0.01% |
50,291
+14
| +0% | +$33 |
|
2505
Pulmonx
LUNG
$52.8M
| $98.4K | ﹤0.01% |
10,634
+13
| +0.1% | +$152 |
|
2506
Tango Therapeutics
TNGX
$4.21B
| $94.8K | ﹤0.01% |
11,895
-13
| -0.1% | -$139 |
|
2507
E.W. Scripps
SSP
$270M
| $91.4K | ﹤0.01% |
23,319
+5
| +0% | +$30 |
|
2508
Petco
WOOF
$797M
| $88K | ﹤0.01% |
38,689
+10
| +0% | +$25 |
|
|
SFIX
2509
Stitch Fix
SFIX
$567M
| $87K | ﹤0.01% |
32,888
+10
| +0% | +$31 |
|
|
SHCR
2510
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $83.9K | ﹤0.01% |
106,152
+2
| +0% | +$2 |
|
2511
Grab Holdings Warrant
GRABW
$530K
| $80.8K | ﹤0.01% |
403,754
| – | – |
|
2512
SES AI
SES
$187M
| $80.7K | ﹤0.01% |
47,917
-31
| -0.1% | -$46 |
|
2513
Angi Inc
ANGI
$247M
| $78K | ﹤0.01% |
2,965
+1
| +0% | +$25 |
|
2514
Funko
FNKO
$346M
| $77.3K | ﹤0.01% |
12,396
+7
| +0.1% | +$49 |
|
|
ME
2515
DELISTED
23andMe Holding Co
ME
| $75.1K | ﹤0.01% |
7,110
-3
| -0% | -$39 |
|
|
SAVE
2516
DELISTED
Spirit Airlines, Inc.
SAVE
| $60K | ﹤0.01% |
12,394
+5
| +0% | +$37 |
|
|
WW
2517
DELISTED
WW International
WW
| $58.6K | ﹤0.01% |
31,598
+4
| +0% | +$16 |
|
|
CTEV
2518
Claritev Corp
CTEV
$399M
| $58.3K | ﹤0.01% |
1,805
| – | – |
|
2519
Heritage Global
HGBL
$41.7M
| $54K | ﹤0.01% |
+20,445
| New | +$58.1K |
|
2520
Ring Energy
REI
$307M
| $46.5K | ﹤0.01% |
+23,729
| New | +$35.3K |
|
2521
Amylyx Pharmaceuticals
AMLX
$2.19B
| $41.9K | ﹤0.01% |
14,717
-36
| -0.2% | -$471 |
|
|
ALUR
2522
DELISTED
Allurion Technologies
ALUR
| $18.3K | ﹤0.01% |
+418
| New | +$30.2K |
|
2523
Aclaris Therapeutics
ACRS
$715M
| – | – |
-20,300
| Closed | -$21.4K |
|
|
AGEN
2524
Agenus
AGEN
$276M
| – | – |
-2,541
| Closed | -$42.1K |
|
2525
Ardagh Metal Packaging
AMBP
$2.96B
| – | – |
-336,595
| Closed | -$1.29M |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.